Reperfusion and metabolic recovery of brain tissue and clinical outcome after ischemic stroke and thrombolytic therapy

Stroke

Volumn 31, Issue 7, 2000, Pages 1545-1551

  Berrouschot, Jörg ^a   Barthel, Henryk ^a   Hesse, Swen ^a   Knapp, Wolfram H ^b   Schneider, Dietmar ^a   Von Kummer, Rüdiger ^c  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Cerebral infarction; Thrombolysis; Tomography, emission computed

Indexed keywords

ALTEPLASE; CYSTEINE ETHYL ESTER TC 99M; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN METABOLISM; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

EID: 0033919288     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.7.1545     Document Type: Article

References (32)

1. NINDS Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne M, Hennerici M. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
3. Thrombolytic therapy with streptokinase in acute ischemic stroke: the Multicenter Acute Stroke Trial: Europe Study Group. N Engl J Med. 1996;335:145-150.
4. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke: Multicentre Acute Stroke Trial-Italy (MAST-I) Group. Lancet. 1995;346:1509-1514.
5. Donnan GA, Davis SM, Chambers BR, Gates PC, Hankey GJ, McNeil JJ, Rosen D, Stewart-Wynne EG, Tuck RR. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. JAMA. 1996;276:961-966.
6. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998;352:1245-1251.
7. Herderschee D, Limburg M, van Royen E, Hijdra A, Büller H, Koster P. Thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: evaluation with rCBF-SPECT. Acta Neurol Scand. 1991; 83:317-322.
8. Overgaard K, Sperling B, Boysen G, Pedersen H, Gam J, Ellemann K, Karle A, Arlien-Soborg P, Olsen T, Videbaeck C, Knudsen J. Thrombolytic therapy in acute ischemic stroke: a Danish pilot study. Stroke. 1993;24:1439-1446.
9. Baird A, Donnan G, Austin M, Fitt G, Davis S, McKay W. Reperfusion after thrombolytic therapy in ischemic stroke measured by single-photon emission computed tomography. Stroke. 1994;25:79-85.
10. Grotta J, Alexandrov A. tPA-associated reperfusion after acute stroke demonstrated by SPECT. Stroke. 1998;29:429-432.
11. Yasaka M, O'Keefe G, Chambers B, Davis S, Infeld B, O'Malley H, Baird A, Hirano T, Donnan G. Streptokinase in acute stroke: effect on reperfusion and recanalization: Australian Streptokinase Trial Study Group. Neurology. 1998;50:626-632.
12. 99mTc-HMPAO imaging. Ann Nucl Med. 1995;9:161-166.
13. Ishizu K, Yonekura Y, Magata Y, Okazawa H, Fukuyama H, Tanaka F, Hattori N, Kitano H, Fujita T, Tamaki N, Konishi J. Extraction and retention of technetium-99m-ECD in human brain: dynamic SPECT and oxygen-15-water PET studies. J Nucl Med. 1996;37:1600-1604.
14. Pessin M, delZoppo G, Estol C. Thrombolytic agents in the treatment of stroke. Clin Neuropharmacol. 1990;13:271-289.
15. 99mTechnetium-ethyl-cysteinate-dimer single-photon emission CT can predict fatal ischemic brain edema. Stroke. 1998;29:2556-2562.
16. Talairach J, Tournoux P. Co-Planar Stereotactic Atlas of the Human Brain. New York, NY: Thieme Verlag; 1988.
17. Podreka I, Suess E, Goldenberg G, Steiner M, Brucke T, Muller C, Lang W, Neirinckx R, Deecke L. Initial experience with technetium-99m HMPAO brain SPECT. J Nucl Med. 1987;28:1657-1666.
18. Hanson SK. Grotta JC, Rhoades H, Tran HD, Lamki LM, Barron BJ, Taylor WJ. Value of single-photon emission-computed tomography in acute stroke therapeutic trials. Stroke. 1993;24:1322-1329.
19. Léveillé J, Demonceau G, De Roo M, Rigo P, Taillefer R, Morgan R, Kupranick D, Walovitch R. Characterization of technetium-99m-L, L-ECD for brain perfusion imaging, part 2: biodistribution and brain imaging in humans. J Nucl Med. 1989;30:1902-1910.
20. Walovitch R, Hill T, Garrity S, Cheesman E, Burgess B, O'Leary D, Watson A, Ganey M, Morgan R, Williams S. Characterization of technetium-99m-L, L-ECD for brain perfusion imaging, pan 1: pharmacology of technetium-99m ECD in nonhuman primates. J Nucl Med. 1989;30: 1892-1901.
21. Walovitch R, Franceschi M, Picard M, Cheesman E, Hall K, Makuch J, Watson M, Zimmerman R, Watson A, Ganey M, Williams S, Holman B. Metabolism of 99m Tc-L-L-ethyl cysteinate dimer in healthy volunteers. Neuropharmacology. 1991;30:283-292.
22. Léveillé J, Demonceau G, Walovitch R. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects. J Nucl Med. 1992;33:480-484.
23. Lassen N, Sperling B. 99mTc-bicisate reliably images CBF in chronic brain diseases but fails to show reflow hyperemia in subacute stroke: report of a multicenter trial of 105 cases comparing 133Xe and 99mTc-bicisate (ECD, neurolite) measured by SPECT on same day. J Cereb Blood Flow Metab. 1994;14(suppl 1):S44-S48.
24. Giubilei F, Lenzi G, Di Piero V, Poizzilli C, Pantano P, Bastianello S, Argentino C, Fieschi C. Predictive value of brain perfusion single-photon emission computed tomography in acute ischemic stroke. Stroke. 1990; 21:895-900.
25. Bozzao L, Angeloni U, Bastianello S, Fantozzi L, Pierallini A, Fieschi C. Early angiographic and CT findings in patients with hemorrhagic infarction in the distribution of the middle cerebral artery. AJNR Am J Neuroradiol. 1992;12:1115-1121.
26. del Zoppo G, von Kummer R, Hamann G. Ischemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke. J Neurol Neurochir Psychiatr. 1998;65:1-9.
27. Ogata J, Yutani C, Imakita M, Ishibashi-Ueda H, Saku Y, Minematsu K, Sawada T, Yamaguchi T. Hemorrhagic infarct of the brain without a reopening of the occluded arteries in cardioembolic stroke. Stroke. 1989; 20:876-883.
28. Ueda T, Sakaki A, Yuh W, Nochide I, Ohta S. Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon-emission-compuled tomography. J Cereb Blood Flow Metab. 1999;19:99-108.
29. von Kummer R, Holle R, Rosin L, Forsting M, Hacke W. Does arterial recanalization improve outcome in carotid territory stroke? Stroke. 1995; 26:581-587.
30. Barber P, Davis S, Infeld B, Baird A, Donnan G, Jolley D, Lichtenstein M. Spontaneous reperfusion after ischemic stroke is associated with improved outcome. Stroke. 1998;29:2522-2528.
31. Marchai G, Furlan M, Beaudouin V, Rioux P, Hauttement J, Serrati C, de la Sayette V, Le Doze F, Viader F, Derlon J, Baron J. Early spontaneous hyperperfusion after stroke: a marker of favourable tissue outcome? Brain. 1996;119:409-419.
32. Marchai G, Young A, Baron J. Early postischemic hyperperfusion: pathophysiologic insights from positron emission tomography. J Cereb Blood Flow Metab. 1999;19:467-482.